Alison Tree

Royal Marsden Hospital, UK


Alison Tree was appointed as a consultant clinical oncologist at the Royal Marsden hospital in 2014, specialising in urological malignancies. She holds an Honorary Faculty position at the Institute of Cancer Research. Her MD thesis was on stereotactic radiotherapy techniques for prostate and oligometastatic cancer.

She is on the NCRI Prostate CSG committee, the UK SABR consortium committee and the editorial board of the International Journal of Radiation Oncology Biology and Physics. She is chief investigator of the TRAP, DELINEATE and PRISM studies, lead for the PACE C trial and co-investigator of the PIVOTALboost and InPACT trials. Her research has received funding from Prostate Cancer UK, Cancer Research UK, the Rosetrees Trust, the JP Moulton foundation, and Elekta. She is prostate lead for the MR Linac consortium. Her current research interests include technical radiotherapy improvements in localised prostate cancer, oligometastatic and oligoprogressive disease.